Heterogeneity of the tumor immune microenvironment and clinical interventions
Frontiers of Medicine · 2023-08 · 17 (4) · 617-648
DOI: 10.1007/s11684-023-1015-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers of Medicine, online erschienen am 20.09.2023. Verfasst von Zheng Jin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Xinqiao Hospital, Army Medical University, Chongqing, 400037, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 296 Literaturangaben.
Abstract (Originalsprache)
The tumor immune microenvironment (TIME) is broadly composed of various immune cells, and its heterogeneity is characterized by both immune cells and stromal cells. During the course of tumor formation and progression and anti-tumor treatment, the composition of the TIME becomes heterogeneous. Such immunological heterogeneity is not only present between populations but also exists on temporal and spatial scales. Owing to the existence of TIME, clinical outcomes can differ when a similar treatment strategy is provided to patients. Therefore, a comprehensive assessment of TIME heterogeneity is essential for developing precise and effective therapies. Facilitated by advanced technologies, it is possible to understand the complexity and diversity of the TIME and its influence on therapy responses. In this review, we discuss the potential reasons for TIME heterogeneity and the current approaches used to explore it. We also summarize clinical intervention strategies based on associated mechanisms or targets to control immunological heterogeneity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Xinqiao Hospital, Army Medical University, Chongqing, 400037, China.
- Key Laboratory of Tumor Immunotherapy, Chongqing, 400037, China.
- Research Institute, GloriousMed Clinical Laboratory (Shanghai) Co. Ltd., Shanghai, 201318, China.
- Institute of Life Sciences, Chongqing Medical University, Chongqing, 400016, China.
- School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, 400054, China.
- Department of Oncology, Xinqiao Hospital, Army Medical University, Chongqing, 400037, China. jeanna@foxmail.com.
Zitieren
APA
Jin, Z., Zhou, Q., Cheng, J. N., Jia, Q., & Zhu, B. (2023). Heterogeneity of the tumor immune microenvironment and clinical interventions. Frontiers of Medicine, 17(4), 617-648. https://doi.org/10.1007/s11684-023-1015-9
Vancouver
Jin Z, Zhou Q, Cheng JN, Jia Q, Zhu B. Heterogeneity of the tumor immune microenvironment and clinical interventions. Frontiers of Medicine. 2023;17(4):617-648. doi:10.1007/s11684-023-1015-9
BibTeX
@article{Jin2023,
author = {Jin, Zheng and Zhou, Qin and Cheng, Jia-Nan and Jia, Qingzhu and Zhu, Bo},
title = {Heterogeneity of the tumor immune microenvironment and clinical interventions},
journal = {Frontiers of Medicine},
year = {2023},
volume = {17},
number = {4},
pages = {617--648},
doi = {10.1007/s11684-023-1015-9}
}
EUVIMED